DCF — HARRIS HEALTH SYSTEM
Enterprise Value: $-349.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-349.8M
Enterprise Value
$-117.0M
PV of Cash Flows
$-232.8M
PV of Terminal Value
$-374.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $407.4M | $-18.3M | -4.0% | $-35.6M | $-32.3M |
| Year 2 | $419.6M | $-14.7M | -3.0% | $-32.4M | $-26.8M |
| Year 3 | $432.2M | $-10.8M | -2.0% | $-29.1M | $-21.9M |
| Year 4 | $445.2M | $-8.9M | -2.0% | $-27.7M | $-19.0M |
| Year 5 | $458.5M | $-8.0M | -2.0% | $-27.4M | $-17.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-349.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$395.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049999998988648764
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5